Skip to content
EntityQ771975· pop 15· linked from 408 articles

antazoline

Sign in to save

Also known as 4,5-Dihydro-N-phenyl-N-phenylmethyl-1H-imidazole-2-methanamine, 2-(N-Benzylanilinomethyl)-2-imidazoline, 2-(N-Phenyl-N-benzylaminomethyl)imidazoline

Antazoline is a 1st generation antihistamine with anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis. To treat allergic conjunctivitis, antazoline can be combined in a solution with tetryzoline. The drug is a Histamine H1 receptor antagonist: selectively binding to but not activating the receptor, thereby blocking the actions of endogenous histamine and subsequently leading to the temporary relief of the negative symptoms brought on by histamine.

Key facts

Drug.image
Antazoline.svg
Drug.image_class
skin-invert-image
Drug.width
215
Drug.tradename
Vasocon-a
Drug.routes_of_administration
Topical (nasal, eye drops)
Drug.ATC_prefix
R01
Drug.ATC_suffix
AC04
Drug.legal_AU
S4
Drug.legal_AU_comment
/Schedule 2
Drug.CAS_number
91-75-8
Drug.PubChem
2200
Drug.IUPHAR_ligand
7116
Drug.DrugBank
DB08799
Drug.ChemSpiderID
2115
Drug.UNII
DHA8014SS1
Drug.KEGG
D07458
Drug.ChEBI
84115
Drug.ChEMBL
1305

via Wikipedia infobox

Wikidata facts

Mass
265.157898
Show 4 more facts
chemical formula
C₁₇H₁₉N₃
canonical SMILES
C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3
World Health Organisation international non-proprietary name
antazoline
Commons category
Antazoline
Sources (2)

via Wikidata · CC0

~1 min read

Article

2 sections
Contents
  • Research
  • References

Antazoline is a 1st generation antihistamine with anticholinergic properties used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis. To treat allergic conjunctivitis, antazoline can be combined in a solution with tetryzoline. The drug is a Histamine H1 receptor antagonist: selectively binding to but not activating the receptor, thereby blocking the actions of endogenous histamine and subsequently leading to the temporary relief of the negative symptoms brought on by histamine.

== Research == A 2015 study on people aged 65 years of age or older linked the development of Alzheimer's disease and other forms of dementia to the "higher cumulative" use of first-generation antihistamines, due to their anticholinergic properties.

Connections

Categories